Referral Training and eGen Trials

December 11, 2025 updated by: University of Minnesota

Child and adolescent behavioral health problems are related to the leading causes of youth morbidity and mortality. Parent-focused interventions effectively prevent behavioral health problems such as depression and conduct disorders and can provide a downstream economic benefit to society by reducing criminal activity, education costs, and health care use.

Unfortunately, parenting programs are not widely available, accessible, nor well-attended.

Pediatric primary care is a non-stigmatizing setting with nearly universal reach and, therefore, an ideal contact point to increase access. However, primary care clinicians (PCCs) often have insufficient training in behavioral health topics and typical referral practices are inadequate.

There are also logistical barriers to attending in-person parenting programs, like the need for childcare and a large time-commitment. There is a need to develop effective referral practices in conjunction with increasing the accessibility of parenting programs. The study long-term goal is to prevent significant behavioral health problems through widespread access to effective and accessible parenting programs through primary care referrals.

In this study there are two trials: First is the primary care clinicians "PCC" trial, testing the effectiveness of referral training (aim 1). Second is the parents "eGen" trial provided by therapists, testing the effectiveness of eGen parenting intervention (aim 2).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

600

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Christopher J Mehus
  • Phone Number: 651-785-3660
  • Email: cjmehus@umn.edu

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • Recruiting
        • University of Minnesota
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Inclusion criteria for parent in the randomized controlled trial include being a parent or caregiver of a child ages 3 to 8 and having a referral to a participating therapist from a primary care provider.
  • The only inclusion criteria is that participants be a PCC who sees children between the ages of 3- 8 years old. PCCs must also have approval from their clinic to participate. Vulnerable populations will not be targeted from inclusion but may be included if they meet the previously stated inclusion criteria.

Exclusion Criteria:

  • Parents would be excluded if there is a reasonable belief that participating could increase danger to a child or if they are psychologically unable to engage in the intervention activities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Primary care clinicians group 1
PCCs with pediatric patients randomized to experimental group
assigned to receive a brief, live, experiential training on the referral process and communication strategies.
Active Comparator: Primary care clinicians group 2
PCCs with pediatric patients randomized to control group
assigned to receive only written information about the referral process
Experimental: Parent group 1
assigned to receive eGen
eGen is a six-session parent training program provided by therapists via video chat online to parents with a child between the ages of 3-8 years.
Active Comparator: Parents group 2
assigned to receive one-session control
The control condition consists of a single scripted session, in which therapists guide the parent to the following resources: (a) a book, Raising Cooperative Kids, by GenPMTO co-developer Marion Forgatch; (b) vetted parenting advice websites; (c) information about Early Childhood and Family Education classes, which are provided for free in Minnesota through public schools; and (d) a list of culturally tailored parenting advice websites.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child behavior problems
Time Frame: 10 weeks
Child externalizing and internalizing will be measured using the Behavioral Assessment System for Children - Behavioral and Emotional Screening System (BASC-3-BESS; 29 items).
10 weeks
Change in parenting behavior
Time Frame: 10 weeks
The Alabama Parenting Questionnaire - Preschool version (APQ; 32 items) has subscales to measure positive parenting, inconsistent parenting, and punitive parenting.
10 weeks
Number of Completed Referrals
Time Frame: 4 years
This is defined as the number of parents who agree to begin treatment with the therapist after a referral from a primary care provider.
4 years
Parent Attendance
Time Frame: 1 year
Parent attendance will be reported as the percent of sessions attended.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parents mental health: depression
Time Frame: 10 weeks
The patient health questionnaire will measure parent depression (PHQ-9; 9 items)
10 weeks
Parents mental health: anxiety
Time Frame: 10 weeks
the general anxiety disorder scale (GAD-7) will assess parent anxiety symptoms
10 weeks
Parents mental health: absenteeism
Time Frame: 10 weeks
the WHO Health and Work Performance Questionnaire - Short Form (HPQ SF, 8 items) will assess parent absenteeism.
10 weeks
Parenting self-efficacy
Time Frame: 10 weeks
Parenting self-efficacy will be measured with the Parent Locus of Control measure (PLOC; 24 items).
10 weeks
Intervention Acceptability, Appropriateness, and Feasibility Measure
Time Frame: 1 year
Average score on the Acceptability of intervention Measure items. These measures are on a 1-5 scale from completely disagree to completely agree. A higher score indicates higher acceptability, appropriateness, or feasibility.
1 year
Readiness to Change - Patient Preferences Subscale Score
Time Frame: 1 year
Average score on the Readiness to Change Assessment, patient preferences items (Helfrich, Li; Sharp, 2009). This measure is rated on a 1-5 scale from strongly disagree to strongly agree, with a sixth option for not applicable. High scores indicates greater acceptability.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher J Mehus, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2025

Primary Completion (Estimated)

November 1, 2028

Study Completion (Estimated)

November 1, 2030

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

November 15, 2024

First Posted (Actual)

November 19, 2024

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavioral Problem

Clinical Trials on Referral and communication skills learning

Subscribe